Ac2-26 TFA

• Description:

  Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  ———

• Molecular Formula:

  ———

• Notes:

  Research use only, not for human use.

• Receptor:

  Other Targets